Filing Details
- Accession Number:
- 0001213900-21-008961
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2021-02-12 16:05:17
- Reporting Period:
- 2020-12-31
- Accepted Time:
- 2021-02-12 16:05:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1726711 | Aditx Therapeutics Inc. | ADTX | Pharmaceutical Preparations (2834) | 823204328 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1817639 | Namvar Kiaie | C/O Aditx Therapeutics, Inc. 2569 Wyandotte St., Suite 101 Mountain View CA 94043 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-02 | 1,111 | $0.00 | 2,222 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-07-22 | 1,111 | $11.25 | 2,222 | No | 5 | X | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 5 | X | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Warrant | Acquisiton | 2020-07-02 | 1,111 | $0.00 | 1,111 | $4.50 |
| Common Stock | Series B Warrant | Acquisiton | 2020-07-02 | 1,111 | $0.00 | 1,111 | $11.25 |
| Common Stock | Series B Warrant | Disposition | 2020-07-22 | 1,111 | $11.25 | 1,111 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,111 | 2020-07-02 | 2025-07-02 | No | 5 | P | Direct |
| 0 | 2020-07-02 | 2025-07-02 | No | 5 | P | Direct |
| 0 | 2020-07-02 | 2025-07-02 | No | 5 | X | Direct |
Footnotes
- The reported securities are included within 1,111 Units purchased by the reporting person for $9.00 per Unit. Each Unit consists of (a) one share of common stock, (b) one Series A Warrant to purchase one share of common stock, and (c) one Series B Warrant to purchase one share of common stock.
Billionaire Hedge Funds
